These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2879412)

  • 41. Influence of (-)-sulpiride and YM-09151-2 on stereotyped behavior in chicks and catalepsy in rats.
    Wambebe C
    Jpn J Pharmacol; 1987 Feb; 43(2):121-8. PubMed ID: 2883335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.
    Pugh MT; O'Boyle KM; Molloy AG; Waddington JL
    Psychopharmacology (Berl); 1985; 87(3):308-12. PubMed ID: 2934758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NNC-19-1228 and NNC 22-0031, novel neuroleptics with a "mesolimbic-selective" behavioral profile.
    Nielsen EB; Hansen JB; Grłnvald FC; Swedberg MD; Scheideler M
    Psychopharmacology (Berl); 1997 Jan; 129(2):168-78. PubMed ID: 9040123
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
    Protais P; Chagraoui A; Arbaoui J; Mocaër E
    Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors.
    Backus LI; Sharp T; Grahame-Smith DG
    Br J Pharmacol; 1990 Aug; 100(4):793-9. PubMed ID: 2145051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
    Iorio LC; Cohen M; Coffin VL
    J Pharmacol Exp Ther; 1991 Jul; 258(1):118-23. PubMed ID: 1830098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. D-2 dopamine antagonist-like effects of SCH 23390 on A9 and A10 dopamine neurons.
    Goldstein JM; Litwin LC; Sutton EB; Malick JB
    Life Sci; 1987 Mar; 40(11):1039-44. PubMed ID: 2950291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine receptor occupancy in vivo: behavioral correlates using NNC-112, NNC-687 and NNC-756, new selective dopamine D1 receptor antagonists.
    Nielsen EB; Andersen PH
    Eur J Pharmacol; 1992 Aug; 219(1):35-44. PubMed ID: 1397048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function.
    Glenthøj B
    Psychopharmacology (Berl); 1993; 113(2):157-66. PubMed ID: 7855176
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.
    Carlson JH; Bergstrom DA; Walters JR
    Eur J Pharmacol; 1986 Apr; 123(2):237-51. PubMed ID: 2940101
    [TBL] [Abstract][Full Text] [Related]  

  • 53. D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity.
    Marin C; Parashos SA; Kapitzoglou-Logothetis V; Peppe A; Chase TN
    Pharmacol Biochem Behav; 1993 May; 45(1):195-200. PubMed ID: 8516358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential attenuation of some effects of haloperidol in rats given scopolamine.
    Setler P; Sarau H; McKenzie G
    Eur J Pharmacol; 1976 Sep; 39(1):117-26. PubMed ID: 986946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats.
    Jelovac N; Sikiric P; Rucman R; Petek M; Marovic A; Perovic D; Seiwerth S; Mise S; Turkovic B; Dodig G; Miklic P; Buljat G; Prkacin I
    Eur J Pharmacol; 1999 Aug; 379(1):19-31. PubMed ID: 10499368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of the dopamine D-1 antagonist SCH 23390 on water intake, water-rewarded operant responding and apomorphine-induced decrease of water intake in rats.
    Ljungberg T
    Pharmacol Biochem Behav; 1989 Jul; 33(3):709-12. PubMed ID: 2685829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuropharmacological profile of a new series of dopamine agonists: N-n-propyl-hexahydronaphthoxazines.
    Hazelhoff B; De Vries JB; Dijkstra D; Mulder TB; Timmermans PB; Wynberg H; Horn AS
    Eur J Pharmacol; 1986 May; 124(1-2):93-106. PubMed ID: 3720849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differences in the cataleptogenic actions of SCH23390 and selected classical neuroleptics.
    Undie AS; Friedman E
    Psychopharmacology (Berl); 1988; 96(3):311-6. PubMed ID: 2906152
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Behavioral pharmacological investigation and clinical consideration of the inhibitory potencies of psychotropic drugs against the D-1 and D-2 dopamine receptors].
    Kazawa T
    Yakubutsu Seishin Kodo; 1986 Sep; 6(3):327-37. PubMed ID: 2949452
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat.
    Dickinson SL; Gadie B; Tulloch IF
    Psychopharmacology (Berl); 1988; 96(4):521-7. PubMed ID: 2907662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.